{
  "paper_id": "PMC9835394",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835394/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1.",
      "caption": "Diagrammatic representation of basal cell carcinoma, squamous cell carcinoma, and melanoma",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/9d45fd4ac39d/12943_2022_1708_Fig1_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/9d45fd4ac39d/12943_2022_1708_Fig1_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/9d45fd4ac39d/12943_2022_1708_Fig1_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/9d45fd4ac39d/12943_2022_1708_Fig1_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/9d45fd4ac39d/12943_2022_1708_Fig1_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9835394/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/9d45fd4ac39d/12943_2022_1708_Fig1_HTML.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Fig. 2.",
      "caption": "An illustration of melanoma progression",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/998a1549a6d7/12943_2022_1708_Fig2_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/998a1549a6d7/12943_2022_1708_Fig2_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/998a1549a6d7/12943_2022_1708_Fig2_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/998a1549a6d7/12943_2022_1708_Fig2_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/998a1549a6d7/12943_2022_1708_Fig2_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9835394/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/998a1549a6d7/12943_2022_1708_Fig2_HTML.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Fig. 3.",
      "caption": "Diagrammatic representation of current treatment approaches for skin cancer and their limitations",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/c73b65b76d5d/12943_2022_1708_Fig3_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/c73b65b76d5d/12943_2022_1708_Fig3_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/c73b65b76d5d/12943_2022_1708_Fig3_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/c73b65b76d5d/12943_2022_1708_Fig3_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/c73b65b76d5d/12943_2022_1708_Fig3_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9835394/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/c73b65b76d5d/12943_2022_1708_Fig3_HTML.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Fig. 4.",
      "caption": "Schematic representation of utilization of nanoparticles in skin cancer therapy",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a5c3a2de0624/12943_2022_1708_Fig4_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a5c3a2de0624/12943_2022_1708_Fig4_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a5c3a2de0624/12943_2022_1708_Fig4_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a5c3a2de0624/12943_2022_1708_Fig4_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig4",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a5c3a2de0624/12943_2022_1708_Fig4_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9835394/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a5c3a2de0624/12943_2022_1708_Fig4_HTML.jpg"
    },
    "figure_5": {
      "figure_number": "Figure 5",
      "title": "Fig. 5.",
      "caption": "A Diagrammatic representation of dacarbazine (DTIC) imbibed cancer cell membrane camouflaged mesoporous silica nanoparticle synthesis process (DTIC@CMSN). B Schematic illustration of antitumor immune response induced by DTIC@CMSN merged with anti-programmed cell death protein 1 antibody (aPD1), reproduced with permission from [107], licensed under CC BY 4.0",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/cd2ca37d756c/12943_2022_1708_Fig5_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/cd2ca37d756c/12943_2022_1708_Fig5_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/cd2ca37d756c/12943_2022_1708_Fig5_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/cd2ca37d756c/12943_2022_1708_Fig5_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig5",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/cd2ca37d756c/12943_2022_1708_Fig5_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9835394/images/figure_5.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/cd2ca37d756c/12943_2022_1708_Fig5_HTML.jpg"
    },
    "figure_6": {
      "figure_number": "Figure 6",
      "title": "Fig. 6.",
      "caption": "In vivo construction of immune cell-based nanomedicine carriers and initial PTT treatment enhance hitchhiking delivery into the tumor and improve antitumor immunotherapy. A E. coli OMVs are coated on both CD-GNPs and ADA-GNPs to prepare bacteria-mimetic nanoparticles. B Selective phagocytosis of bacteria-mimetic nanoparticles by phagocytic immune cells induces OMV degradation and subsequent intracellular aggregation of GNPs mediated by CD-ADA host–guest interactions, leading to photothermal property due to the plasmonic effects of GNP aggregates. The large size of intracellular GNP aggregates also inhibits the leakage during in vivo cell-hitchhiking delivery. Because of the inflammatory tropism to melanoma, immune cells achieve the targeted delivery of intracellular GNP aggregates to the tumor tissues. C Initial PTT treatment of GNP aggregates induces tumor damage that subsequently enhances inflammatory signals and provides positive feedback to recruit more immune cells (including the carriers) for enhanced antitumor therapy. Secondary photothermal treatment (PTT) of Mixture induces tumor cell immunogenic cell death (ICD) and activates antitumor immune response, further strengthened by immune checkpoint blockage (aPD-L1), reproduced with permission from [168], licensed under CC BY 4.0",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/310c3b27143c/12943_2022_1708_Fig6_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/310c3b27143c/12943_2022_1708_Fig6_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/310c3b27143c/12943_2022_1708_Fig6_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/310c3b27143c/12943_2022_1708_Fig6_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig6",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/310c3b27143c/12943_2022_1708_Fig6_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9835394/images/figure_6.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/310c3b27143c/12943_2022_1708_Fig6_HTML.jpg"
    },
    "figure_7": {
      "figure_number": "Figure 7",
      "title": "Fig. 7.",
      "caption": "Schematic illustration of the design and therapeutic strategy of SHP. Part I: Synthesis of PAE and preparation of SHP micelle from the PAE, HA and SCP. Part II: Topical application of SHP/SiRNA induces survivin slicing in skin melanoma. (1) SHP/SiRNA nanocomplexes penetrate through the skin stratum corneum and target to melanoma locates at the interface of epidermis and dermis. (2) SHP/SiRNA-survivin nanocomplexes are uptaken by melanoma cells. (3) SHP/SiRNAsurvivin nanocomplexes escaped from the lysosome, release the siRNA that bind to the targeting RNA, followed by slicing survivin, which possesses the great potential to induce the significant apoptosis to melanoma cells in vitro and retard the melanoma progression in vivo, reproduced with permission from [249], copyright 2020, Elsevier",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a1f54cabc102/12943_2022_1708_Fig7_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a1f54cabc102/12943_2022_1708_Fig7_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a1f54cabc102/12943_2022_1708_Fig7_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a1f54cabc102/12943_2022_1708_Fig7_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig7",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a1f54cabc102/12943_2022_1708_Fig7_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9835394/images/figure_7.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/a1f54cabc102/12943_2022_1708_Fig7_HTML.jpg"
    },
    "figure_8": {
      "figure_number": "Figure 8",
      "title": "Fig. 8.",
      "caption": "Illustration of cRGD-installed reduction-responsive crosslinked nanotherapeutics from star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) for enhanced DOX delivery to B16F10 melanoma bearing mice in vivo, reproduced with permission from [277], copyright 2019, American Chemical Society",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/2df1d770c6d5/12943_2022_1708_Fig8_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/2df1d770c6d5/12943_2022_1708_Fig8_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/2df1d770c6d5/12943_2022_1708_Fig8_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/2df1d770c6d5/12943_2022_1708_Fig8_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig8",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/2df1d770c6d5/12943_2022_1708_Fig8_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9835394/images/figure_8.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/2df1d770c6d5/12943_2022_1708_Fig8_HTML.jpg"
    },
    "figure_9": {
      "figure_number": "Figure 9",
      "title": "Fig. 9.",
      "caption": "Schematic illustration of the formation of P/LNV loaded with tumor vaccines and IDO inhibitor (P/LNV@IDO/AE/CpG) and the action mechanism for immunotherapy (A) Preparation of P/LNV@IDO/AE/CpG. B Combination immunotherapy induced by P/LNV@IDO/AE/CpG. Naive dendritic cells (DCs) are activated and their maturation is induced by the antigens delivered by P/LNV@IDO/AE/CpG, which then present the processed peptide antigens to T cells, causing a strong cytotoxic T-lymphocyte (CTL) response. Tumor cells would be attacked by effector T cells. Besides, the presentation of 1-MT would inhibit the activity of IDO by decreasing the oxidization of tryptophan (Trp) to kynurenine (Krn), which further enhanced the antitumor immune response. Together, P/LNV@IDO/AE/CpG resulted in a superior combination immunotherapy against melanoma, reproduced with permission from [334], copyright 2021, Royal Society of Chemistry",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/8d87cb2f8185/12943_2022_1708_Fig9_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/8d87cb2f8185/12943_2022_1708_Fig9_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/8d87cb2f8185/12943_2022_1708_Fig9_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/8d87cb2f8185/12943_2022_1708_Fig9_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig9",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/8d87cb2f8185/12943_2022_1708_Fig9_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9835394/images/figure_9.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/8d87cb2f8185/12943_2022_1708_Fig9_HTML.jpg"
    },
    "figure_10": {
      "figure_number": "Figure 10",
      "title": "Fig. 10.",
      "caption": "Diagrammatic representation of spatiotemporally controlled pulsatile release microneedle drug delivery system for the treatment of melanoma, reproduced with permission from [377], licensed under CC BY 4.0",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/037a96a6f5b2/12943_2022_1708_Fig10_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/037a96a6f5b2/12943_2022_1708_Fig10_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/037a96a6f5b2/12943_2022_1708_Fig10_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/037a96a6f5b2/12943_2022_1708_Fig10_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig10",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/037a96a6f5b2/12943_2022_1708_Fig10_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9835394/images/figure_10.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74af/9835394/037a96a6f5b2/12943_2022_1708_Fig10_HTML.jpg"
    }
  },
  "claims": [
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A brief description of currently practiced treatment strategies for skin cancer therapy is narrated below (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The NPs are further classified into three categories, i.e., inorganic NPs, polymer-based NPs, and lipid-based NPs (Fig. \n4\n).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "However, under no NIR irradiation, the reduced temperature is witnessed, facilitating the re-solidification of SLNs, further inhibiting PTX delivery (Fig. 10).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A brief description of currently practiced treatment strategies for skin cancer therapy is narrated below (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The NPs are further classified into three categories, i.e., inorganic NPs, polymer-based NPs, and lipid-based NPs (Fig. \n4\n).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "However, under no NIR irradiation, the reduced temperature is witnessed, facilitating the re-solidification of SLNs, further inhibiting PTX delivery (Fig. 10).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A brief description of currently practiced treatment strategies for skin cancer therapy is narrated below (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The NPs are further classified into three categories, i.e., inorganic NPs, polymer-based NPs, and lipid-based NPs (Fig. \n4\n).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "However, under no NIR irradiation, the reduced temperature is witnessed, facilitating the re-solidification of SLNs, further inhibiting PTX delivery (Fig. 10).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A brief description of currently practiced treatment strategies for skin cancer therapy is narrated below (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The NPs are further classified into three categories, i.e., inorganic NPs, polymer-based NPs, and lipid-based NPs (Fig. \n4\n).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "However, under no NIR irradiation, the reduced temperature is witnessed, facilitating the re-solidification of SLNs, further inhibiting PTX delivery (Fig. 10).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A brief description of currently practiced treatment strategies for skin cancer therapy is narrated below (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The NPs are further classified into three categories, i.e., inorganic NPs, polymer-based NPs, and lipid-based NPs (Fig. \n4\n).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "However, under no NIR irradiation, the reduced temperature is witnessed, facilitating the re-solidification of SLNs, further inhibiting PTX delivery (Fig. 10).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A brief description of currently practiced treatment strategies for skin cancer therapy is narrated below (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The NPs are further classified into three categories, i.e., inorganic NPs, polymer-based NPs, and lipid-based NPs (Fig. \n4\n).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "However, under no NIR irradiation, the reduced temperature is witnessed, facilitating the re-solidification of SLNs, further inhibiting PTX delivery (Fig. 10).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A brief description of currently practiced treatment strategies for skin cancer therapy is narrated below (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The NPs are further classified into three categories, i.e., inorganic NPs, polymer-based NPs, and lipid-based NPs (Fig. \n4\n).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "However, under no NIR irradiation, the reduced temperature is witnessed, facilitating the re-solidification of SLNs, further inhibiting PTX delivery (Fig. 10).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A brief description of currently practiced treatment strategies for skin cancer therapy is narrated below (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The NPs are further classified into three categories, i.e., inorganic NPs, polymer-based NPs, and lipid-based NPs (Fig. \n4\n).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "However, under no NIR irradiation, the reduced temperature is witnessed, facilitating the re-solidification of SLNs, further inhibiting PTX delivery (Fig. 10).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The superficial BCC is characterized by a smooth or red stain in the epidermis with limited or nil invasion into the dermis (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "SCC is distinguished by an atypical proliferation of invasive squamous cells that could metastasize into various parts of the body (Fig. 1) [52].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Melanoma arises from pigment (melanin) producing cells called melanocytes with uncontrollable division causing metastatic events (Fig. 1) [57].",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The actual stages of melanoma are shown in Table 1 and Fig. 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "A brief description of currently practiced treatment strategies for skin cancer therapy is narrated below (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "A brief description of currently practiced treatment strategies for skin cancer therapy is narrated below (Fig. 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The NPs are further classified into three categories, i.e., inorganic NPs, polymer-based NPs, and lipid-based NPs (Fig. \n4\n).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The NPs are further classified into three categories, i.e., inorganic NPs, polymer-based NPs, and lipid-based NPs (Fig. \n4\n).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Thus, the authors came up with the idea of coating cancer cell membrane (CCM) on DTIC@MSNs via extrusion method that resulted in a particle size of 151 nm (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Finally, the authors used anti-programmed cell death protein 1 antibody (aPD1) along with DTIC@CMSNs to mitigate the immune’s negative feedback pathway throughout the action of chemotherapeutics (Fig. 5).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        },
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "In order to find a solution to the above problem, Gao and co-workers reported a unique technique to stably hitchhike phagocytic immune cells through specific phagocytosis of bacteria-imitating AuNPs followed by concurrent self-assembly via a supramolecular mechanism inside the cancer cell (Fig. 6) [168].",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        },
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Next, the authors used this polymer (SCP-HA-PAE) to develop pH-switchable siRNA@PMs (siRNA@SHP) for treating cutaneous melanoma via a topical route (Fig. 7).",
      "figure_references": [
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        },
        {
          "figure_number": "Figure 7",
          "panel": "",
          "figure_key": "figure_7"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Further, the most commonly adopted biodegradable synthetic and natural polymers to develop this kind of NPs are poly(lactide-co-glycolide) (PLGA) [270], polylactide (PLA) [271], polycaprolactone (PCL) [272], PLGA-polyethylene glycol (PEG) [273], alginate [274], gelatin [275], albumin [276], etc. Recently, an investigation by Wang and colleagues developed DOX-loaded cRGD-attached reduction-responsive crosslinked nanotherapeutics based on star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) to achieve targeted delivery to melanoma (Fig. 8) [277].",
      "figure_references": [
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        },
        {
          "figure_number": "Figure 8",
          "panel": "",
          "figure_key": "figure_8"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "Further, they complexed (electrostatically) the liposomes with negatively charged epitopes (AE) that were derived from antigens of melanoma followed by conjugation of a strong TLR9 agonist, i.e., CpG, to yield a unique tumor vaccine (Fig. 9).",
      "figure_references": [
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        },
        {
          "figure_number": "Figure 9",
          "panel": "",
          "figure_key": "figure_9"
        }
      ]
    },
    {
      "sentence": "However, under no NIR irradiation, the reduced temperature is witnessed, facilitating the re-solidification of SLNs, further inhibiting PTX delivery (Fig. 10).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        }
      ]
    },
    {
      "sentence": "However, under no NIR irradiation, the reduced temperature is witnessed, facilitating the re-solidification of SLNs, further inhibiting PTX delivery (Fig. 10).",
      "figure_references": [
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        },
        {
          "figure_number": "Figure 10",
          "panel": "",
          "figure_key": "figure_10"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 10,
    "claims_count": 140,
    "images_downloaded": 10,
    "tables_filtered": 19
  }
}